<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate™ for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

2 min read

ASGCT 26th Annual Meeting

ASGCT 26th Annual Meeting

Date: May 16-20, 2023

Booth: #107

Location: Los Angeles Convention Center in Los Angeles, CA - Directions

Event Website: https://annualmeeting.asgct.org/



Interested in learning more about our global network and capabilities? Click the button below or email one of our representatives at the event to set up a meeting.

Click the link above to get all the details. 



Friday May 19, Exhibitor Showcase: learn how to Navigate Vector Production Complexities

Our Director of Vector Development Margherita Neri is presenting at this year's ASGCT Exhibitor's showcase. Come join us for a presentation on  how you can navigate the complexities of viral vector production for gene therapies. We're excited to share more details about the processes to use, and key features of our adeno-associated and lentivral vector platforms.

Join us Friday, May 19 @ 9:15am for Dr. Neri's presentation:

Navigating Complexities of Viral Vector Production for Gene Therapies. 

Exhibition Hall 511 on floor 2. 

You can also reach out directly to our experts attending the show

Luca Alberici
General Manager, Site Head - Milan
Email  me
Giuliana Vallanti
Vice President, Development and R&D Global Cell and Gene
Email me
Maggie Chen
Sr. Director, Manufacturing
Email  me
Margherita Neri
Vector Process Development Director
Email me
Raghu Malapaka
Sr. Director, Business Development
Email me

Learn about our cell and gene therapy services 

Cell Therapy Production and Manufacturing

AGC Biologics’ cell therapy services support every stage of the product journey, from pre-clinical through commercialization. At our Milan and Longmont facilities, we can work with virtually any cell type – including Human Mesenchymal Stem Cells (hMSCs), Exosomes, CD34+, T-Cells, NK Cells, and more.  

Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting. 

Learn more about our overall cell therapy offering 

Viral Vector Production and Manufacturing 

AGC Biologics scientists have two decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products. 

Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house. 

Discover more about our viral vector services 

Plasmid DNA (pDNA) Materials 

To support your pDNA needs, AGC Biologics utilizes a customized process based on your specific plasmid and hosting system. We have extensive technical expertise in fermentation, purification, and analytics, and our highly experienced teams routinely manufacture GMP-grade pDNA materials. This work includes starting material for gene therapy, and viral vector manufacturing. 

Learn more about our Plasmid offering

Fill out the form below to request a meeting during the event